Astex Awarded The Sunday Times Microsoft Tech Track 100 Research and Development Award 2004
02 déc. 2004 06h57 HE
|
Astex Therapeutics
CAMBRIDGE, United Kingdom, Dec. 02, 2004 (PRIMEZONE) --
* Astex Technology, the fragment-based drug discovery and
development company, received the Research and Development Award
...
Astex achieves drug discovery collaboration success with Schering AG
25 oct. 2004 02h34 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., Oct. 25, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery and development company, today announced that it has completed a significant goal in its multi-target...
Astex strengthens management team -- Martin Buckland joins as Senior Vice President, Business Development
11 oct. 2004 03h34 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., Oct. 11, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery and development company, today announced the appointment of Dr Martin Buckland as Senior Vice...
Astex ranked top biotech company for the second year running in The Sunday Times Microsoft Tech Track 100
05 oct. 2004 09h39 HE
|
Astex Therapeutics
CAMBRIDGE, United Kingdom, Oct. 5, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, is again ranked as the fastest growing biotechnology company in the Sunday Times...
Astex Reveals Structure of Key Drug Metabolizing Enzyme -- Cytochrome P450 3A4 -- in Science
16 juil. 2004 02h40 HE
|
Astex Therapeutics
CAMBRIDGE, United Kingdom, July 16, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery and development company, today announced that its scientists had published the...
Astex Extends Research Collaboration with Aventis
08 juin 2004 02h45 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., June 8, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery and development company, today announced that it has extended its existing structural biology research...
Astex Achieves Second Milestone in Alzheimer's Drug Discovery Collaboration with AstraZeneca
19 avr. 2004 02h15 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., April 19, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, today announced that it has received the second milestone payment from AstraZeneca as part...
Astex, The Wellcome Trust, The Institute of Cancer Research and Cancer Research Technology Announce Major Cancer Drug Discovery Collaboration
22 mars 2004 03h33 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., March 22, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, together with The Wellcome Trust, the Institute of Cancer Research and Cancer Research...
Astex Announces Drug Discovery Alliance with Boehringer Ingelheim
09 mars 2004 02h10 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., March 9, 2004 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, today announced a three year, multi-target-based, alliance with Boehringer Ingelheim for the...
Astex Strengthens Oncology Expertise -- Director of Oncology Joins Management Team
12 nov. 2003 04h12 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., Nov. 12, 2003 (PRIMEZONE) -- Astex Technology, the fragment-based drug discovery company, today announced the appointment of Dr John Lyons as Director of Oncology. Dr Lyons will...